-
1
-
-
47949089607
-
Acinetobacter baumannii: Emergence of a successful pathogen
-
Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: Emergence of a successful pathogen. Clin. Microbiol. Rev. 21(3), 538-582 (2008
-
(2008)
Clin. Microbiol. Rev
, vol.21
, Issue.3
, pp. 538-582
-
-
Peleg, A.Y.1
Seifert, H.2
Paterson, D.L.3
-
2
-
-
79955611439
-
Global spread of multi-drug-resistant Acinetobacter baumannii: Molecular epidemiology and management of antimicrobial resistance
-
Durante-Mangoni E, Zarrilli R. Global spread of multi-drug-resistant Acinetobacter baumannii: Molecular epidemiology and management of antimicrobial resistance. Future Microbiol. 6(4), 407-422 (2011
-
(2011)
Future Microbiol
, vol.6
, Issue.4
, pp. 407-422
-
-
Durante-Mangoni, E.1
Zarrilli, R.2
-
3
-
-
84857646835
-
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance
-
Magiorakos AP, Srinivasan A, Carey RB et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect. 18(3), 268-281 (2012
-
(2012)
Clin. Microbiol. Infect
, vol.18
, Issue.3
, pp. 268-281
-
-
Magiorakos, A.P.1
Srinivasan, A.2
Carey, R.B.3
-
4
-
-
84887666298
-
TEM-1 β-lactamase as a source of resistance to sulbactam in clinical strains of Acinetobacter baumannii
-
Krizova L, Poirel L, Nordmann P, Nemec A. TEM-1 β-lactamase as a source of resistance to sulbactam in clinical strains of Acinetobacter baumannii. J. Antimicrob. Chemother. 68(12), 2786-2791 (2013
-
(2013)
J. Antimicrob. Chemother
, vol.68
, Issue.12
, pp. 2786-2791
-
-
Krizova, L.1
Poirel, L.2
Nordmann, P.3
Nemec, A.4
-
5
-
-
0343185958
-
Cloning, nucleotide sequencing, and analysis of the gene encoding an AmpC β-lactamase in Acinetobacter baumannii
-
Bou G, Martínez-Beltrán J. Cloning, nucleotide sequencing, and analysis of the gene encoding an AmpC β-lactamase in Acinetobacter baumannii. Antimicrob. Agents Chemother. 44(2), 428-432 (2000
-
(2000)
Antimicrob. Agents Chemother
, vol.44
, Issue.2
, pp. 428-432
-
-
Bou, G.1
Martínez-Beltrán, J.2
-
6
-
-
79251524206
-
Effect of frameshift mutagen acriflavine on control of resistance genes in Acinetobacter baumannii
-
Lopes BS, Hamouda A, Findlay J, Amyes SGB. Effect of frameshift mutagen acriflavine on control of resistance genes in Acinetobacter baumannii. J. Med. Microbiol. 60(Pt 2), 211-215 (2011
-
(2011)
J. Med. Microbiol
, vol.60
, Issue.PART 2
, pp. 211-215
-
-
Lopes, B.S.1
Hamouda, A.2
Findlay, J.3
Amyes, S.G.B.4
-
7
-
-
73849084148
-
Diversity, epidemiology and genetics of class D β-lactamases
-
Poirel L, Naas T, Nordmann P. Diversity, epidemiology and genetics of class D β-lactamases. Antimicrob. Agents Chemother. 54(1), 24-38 (2010
-
(2010)
Antimicrob. Agents Chemother
, vol.54
, Issue.1
, pp. 24-38
-
-
Poirel, L.1
Naas, T.2
Nordmann, P.3
-
8
-
-
33750586663
-
VEB-1 extended-spectrum β-lactamase producing Acinetobacter baumannii
-
Naas T, Coignard B, Carbonne A et al. VEB-1 extended-spectrum β-lactamase producing Acinetobacter baumannii, France. Emerg. Infect. Dis. 12(8), 1214-1222 (2006
-
(2006)
France. Emerg. Infect. Dis
, vol.12
, Issue.8
, pp. 1214-1222
-
-
Naas, T.1
Coignard, B.2
Carbonne, A.3
-
9
-
-
33748711682
-
Emergence of PER-2 and VEB-1a in Acinetobacter baumannii strains in the Americas
-
Pasterán F, Rapoport M, Petroni A et al. Emergence of PER-2 and VEB-1a in Acinetobacter baumannii strains in the Americas. Antimicrob. Agents Chemother. 50(9), 3222-3224 (2006
-
(2006)
Antimicrob. Agents Chemother
, vol.50
, Issue.9
, pp. 3222-3224
-
-
Pasterán, F.1
Rapoport, M.2
Petroni, A.3
-
10
-
-
34250191096
-
Spread in an Italian hospital of a clonal Acinetobacter baumannii strain producing the TEM-92 extended spectrum β-lactamase
-
Endimiani A, Luzzaro F, Migliavacca R et al. Spread in an Italian hospital of a clonal Acinetobacter baumannii strain producing the TEM-92 extended spectrum β-lactamase. Antimicrob Agents Chemother. 51(6), 2211-2214 (2007
-
(2007)
Antimicrob Agents Chemother
, vol.51
, Issue.6
, pp. 2211-2214
-
-
Endimiani, A.1
Luzzaro, F.2
Migliavacca, R.3
-
11
-
-
35448967975
-
Panresistant extended spectrum β-lactamase shv-5-producing acinetobacter baumannii from new york city
-
Naas T, Namdari F, R?glier-Poupet H, Poyart C, Nordmann P. Panresistant extended spectrum β-lactamase SHV-5-producing Acinetobacter baumannii from New York City. J. Antimicrob. Chemother. 60(5), 1174-1176 (2007
-
(2007)
J. Antimicrob. Chemother
, vol.60
, Issue.5
, pp. 1174-1176
-
-
Naas, T.1
Namdari, F.2
Réglier-Poupet, H.3
Poyart, C.4
Nordmann, P.5
-
12
-
-
4644315827
-
Nosocomial transmission of CTX-M-2 β lactamase producing Acinetobacter baumannii in a neurosurgery ward
-
Nagano N, Nagano Y, Cordevant C, Shibata N, Arakawa Y. Nosocomial transmission of CTX-M-2 β lactamase producing Acinetobacter baumannii in a neurosurgery ward. J. Clin. Microbiol. 42(9), 3978-3984 (2004
-
(2004)
J. Clin. Microbiol
, vol.42
, Issue.9
, pp. 3978-3984
-
-
Nagano, N.1
Nagano, Y.2
Cordevant, C.3
Shibata, N.4
Arakawa, Y.5
-
13
-
-
11144280127
-
Dissemination and diversity of metallo-betalactamases in Latin America: Report from the SENTRY Antimicrobial Surveillance Program
-
Sader HS, Castanheira M, Mendes RE, Toleman M, Walsh TR, Jones RN. Dissemination and diversity of metallo-betalactamases in Latin America: Report from the SENTRY Antimicrobial Surveillance Program. Int. J. Antimicrob. Agents 25(1), 57-61 (2005
-
(2005)
Int. J. Antimicrob. Agents
, vol.25
, Issue.1
, pp. 57-61
-
-
Sader, H.S.1
Castanheira, M.2
Mendes, R.E.3
Toleman, M.4
Walsh, T.R.5
Jones, R.N.6
-
14
-
-
33744909136
-
VIM-1 metallo-beta-lactamase in Acinetobacter baumannii
-
Tsakris A, Ikonomidis A, Pournaras S et al. VIM-1 metallo-beta-lactamase in Acinetobacter baumannii. Emerg. Infect. Dis. 12(6), 981-983 (2006
-
(2006)
Emerg. Infect. Dis
, vol.12
, Issue.6
, pp. 981-983
-
-
Tsakris, A.1
Ikonomidis, A.2
Pournaras, S.3
-
15
-
-
27644562636
-
Novel acquired metallo-beta-lactamase gene, bla(SIM-1), in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea
-
Lee K, Yum JH, Yong D et al. Novel acquired metallo-beta-lactamase gene, bla(SIM-1), in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea. Antimicrob. Agents Chemother. 49(11), 4485-4491 (2005
-
(2005)
Antimicrob. Agents Chemother
, vol.49
, Issue.11
, pp. 4485-4491
-
-
Lee, K.1
Yum, J.H.2
Yong, D.3
-
16
-
-
84865289239
-
Dissemination of New Delhi metallo-β-lactamase-1-producing Acinetobacter baumannii in Europe
-
Bonnin RA, Poirel L, Naas T et al. Dissemination of New Delhi metallo-β-lactamase-1-producing Acinetobacter baumannii in Europe. Clin. Microbiol. Infect. 18(9), E362-E365 (2012
-
(2012)
Clin. Microbiol. Infect
, vol.18
, Issue.9
-
-
Bonnin, R.A.1
Poirel, L.2
Naas, T.3
-
17
-
-
80054691512
-
Dissemination of an NDM-2-producing Acinetobacter baumannii clone in an Israeli rehabilitation center
-
Espinal P, Fugazza G, López Y et al. Dissemination of an NDM-2-producing Acinetobacter baumannii clone in an Israeli rehabilitation center. Antimicrob. Agents Chemother. 55(11), 5396-5398 (2011
-
(2011)
Antimicrob. Agents Chemother
, vol.55
, Issue.11
, pp. 5396-5398
-
-
Espinal, P.1
Fugazza, G.2
López, Y.3
-
19
-
-
78650638190
-
Carbapenem hydrolyzing GES-Type extended-spectrum beta-lactamase in Acinetobacter baumannii
-
Bonnin RA, Nordmann P, Potron A, Lecuyer H, Zahar JR, Poirel L. Carbapenem hydrolyzing GES-Type extended-spectrum beta-lactamase in Acinetobacter baumannii. Antimicrob. Agents Chemother. 55(1), 349-354 (2011
-
(2011)
Antimicrob. Agents Chemother
, vol.55
, Issue.1
, pp. 349-354
-
-
Bonnin, R.A.1
Nordmann, P.2
Potron, A.3
Lecuyer, H.4
Zahar, J.R.5
Poirel, L.6
-
20
-
-
71549143174
-
Heteroresistance to meropenem in carbapenem-susceptible Acinetobacter baumannii
-
Ikonomidis A, Neou E, Gogou V, Vrioni G, Tsakris A, Pournaras S. Heteroresistance to meropenem in carbapenem-susceptible Acinetobacter baumannii. J. Clin. Microbiol. 47(12), 4055-4059 (2009
-
(2009)
J. Clin. Microbiol
, vol.47
, Issue.12
, pp. 4055-4059
-
-
Ikonomidis, A.1
Neou, E.2
Gogou, V.3
Vrioni, G.4
Tsakris, A.5
Pournaras, S.6
-
21
-
-
33845450679
-
Global comparison of the membrane subproteomes between a multidrug-resistant Acinetobacter baumannii strain and a reference strain
-
Siroy A, Cosette P, Seyer D et al. Global comparison of the membrane subproteomes between a multidrug-resistant Acinetobacter baumannii strain and a reference strain. J. Proteome Res. 5(12), 3385-3398 (2006
-
(2006)
J. Proteome Res
, vol.5
, Issue.12
, pp. 3385-3398
-
-
Siroy, A.1
Cosette, P.2
Seyer, D.3
-
22
-
-
28844445544
-
Channel formation by CarO, the carbapenem resistance-Associated outer membrane protein of Acinetobacter baumannii
-
Siroy A, Molle V, Lemaitre-Guillier C et al. Channel formation by CarO, the carbapenem resistance-Associated outer membrane protein of Acinetobacter baumannii. Antimicrob. Agents Chemother. 49(12), 4876-4883 (2005
-
(2005)
Antimicrob. Agents Chemother
, vol.49
, Issue.12
, pp. 4876-4883
-
-
Siroy, A.1
Molle, V.2
Lemaitre-Guillier, C.3
-
23
-
-
80053608359
-
Genome organization of epidemic Acinetobacter baumannii strains
-
Di Nocera PP, Rocco F, Giannouli M, Triassi M, Zarrilli R. Genome organization of epidemic Acinetobacter baumannii strains. BMC Microbiol. 11, 224 (2011
-
(2011)
BMC Microbiol
, vol.11
, Issue.224
-
-
Di Nocera, P.P.1
Rocco, F.2
Giannouli, M.3
Triassi, M.4
Zarrilli, R.5
-
24
-
-
0029035984
-
Mutation in the gyrA gene of quinoloneresistant clinical isolates of Acinetobacter baumannii
-
Vila J, Ruiz J, Goñi P, Marcos A, de Anta TJ. Mutation in the gyrA gene of quinoloneresistant clinical isolates of Acinetobacter baumannii. Antimicrob. Agents Chemother. 39(5), 1201-1203 (1995
-
(1995)
Antimicrob. Agents Chemother
, vol.39
, Issue.5
, pp. 1201-1203
-
-
Vila, J.1
Ruiz, J.2
Goñi, P.3
Marcos, A.4
De Anta, T.J.5
-
25
-
-
0030851997
-
Quinolone-resistance mutations in the topoisomerase IV parC gene of Acinetobacter baumannii
-
Vila J, Ruiz J, Goni P, de Anta TJ. Quinolone-resistance mutations in the topoisomerase IV parC gene of Acinetobacter baumannii. J. Antimicrob. Chemother. 39(6), 757-762 (1997
-
(1997)
J. Antimicrob. Chemother
, vol.39
, Issue.6
, pp. 757-762
-
-
Vila, J.1
Ruiz, J.2
Goni, P.3
De Anta, T.J.4
-
26
-
-
9244250185
-
Diversity of aminoglycoside-resistance genes and their association with class 1 integrons among strains of pan-European Acinetobacter baumannii clones
-
Nemec A, Dolzani L, Brisse S, van Den Broek P, Dijkshoorn L. Diversity of aminoglycoside-resistance genes and their association with class 1 integrons among strains of pan-European Acinetobacter baumannii clones. J. Med. Microbiol. 53(12), 1233-1240 (2004
-
(2004)
J. Med. Microbiol
, vol.53
, Issue.12
, pp. 1233-1240
-
-
Nemec, A.1
Dolzani, L.2
Brisse, S.3
Van Den Broek, P.4
Dijkshoorn, L.5
-
27
-
-
34547849631
-
Widespread occurrence of aminoglycoside resistance due to ArmA methylase in imipenem-resistant Acinetobacter baumannii isolates in China
-
Yu YS, Zhou H, Yang Q, Chen YG, Li LJ. Widespread occurrence of aminoglycoside resistance due to ArmA methylase in imipenem-resistant Acinetobacter baumannii isolates in China. J. Antimicrob. Chemother. 60(2), 454-455 (2007
-
(2007)
J. Antimicrob. Chemother
, vol.60
, Issue.2
, pp. 454-455
-
-
Yu, Y.S.1
Zhou, H.2
Yang, Q.3
Chen, Y.G.4
Li, L.J.5
-
28
-
-
77954753589
-
AdeABC-mediated efflux and tigecycline MICs for epidemic clones of Acinetobacter baumannii
-
Hornsey M, Ellington MJ, Doumith M et al. AdeABC-mediated efflux and tigecycline MICs for epidemic clones of Acinetobacter baumannii. J. Antimicrob. Chemother. 65(8), 1589-1593 (2010
-
(2010)
J. Antimicrob. Chemother
, vol.65
, Issue.8
, pp. 1589-1593
-
-
Hornsey, M.1
Ellington, M.J.2
Doumith, M.3
-
29
-
-
70349136689
-
Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system
-
Adams MD, Nickel GC, Bajaksouzian S et al. Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system. Antimicrob. Agents Chemother. 53(9), 3628-3634 (2009
-
(2009)
Antimicrob. Agents Chemother
, vol.53
, Issue.9
, pp. 3628-3634
-
-
Adams, M.D.1
Nickel, G.C.2
Bajaksouzian, S.3
-
30
-
-
79959261544
-
Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system
-
Beceiro A, Llobet E, Aranda J et al. Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system. Antimicrob. Agents Chemother. 55(7), 3370-3379 (2011
-
(2011)
Antimicrob. Agents Chemother
, vol.55
, Issue.7
, pp. 3370-3379
-
-
Beceiro, A.1
Llobet, E.2
Aranda, J.3
-
31
-
-
84887274632
-
Emergence of colistin-resistance in extremely drug-resistant Acinetobacter baumannii containing a novel pmrCAB operon during colistin therapy of wound infections
-
Lesho E, Yoon EJ, McGann P et al. Emergence of colistin-resistance in extremely drug-resistant Acinetobacter baumannii containing a novel pmrCAB operon During colistin therapy of wound infections. J. Infect. Dis. 208(7), 1142-1151 (2013
-
(2013)
J. Infect. Dis
, vol.208
, Issue.7
, pp. 1142-1151
-
-
Lesho, E.1
Yoon, E.J.2
McGann, P.3
-
32
-
-
84879590434
-
Clinical use of colistin induces crossresistance to host antimicrobials in Acinetobacter baumannii
-
Napier BA, Burd EM, Satola SW et al. Clinical use of colistin induces crossresistance to host antimicrobials in Acinetobacter baumannii. MBio 4(3), e00021-13 (2013
-
(2013)
MBio
, vol.4
, Issue.3
-
-
Napier, B.A.1
Burd, E.M.2
Satola, S.W.3
-
33
-
-
78649650250
-
Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production
-
Moffatt JH, Harper M, Harrison P et al. Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production. Antimicrob. Agents Chemother. 54(12), 4971-4977 (2010
-
(2010)
Antimicrob. Agents Chemother
, vol.54
, Issue.12
, pp. 4971-4977
-
-
Moffatt, J.H.1
Harper, M.2
Harrison, P.3
-
34
-
-
0037378074
-
Epidemiology of rifampin adp-ribosyltransferase (arr-2) and metallo-beta-lactamase (blaimp-4) gene cassettes in class 1 integrons in acinetobacter strains isolated from blood cultures in 1997 to 2000
-
Houang ET, Chu YW, Lo WS, Chu KJ, Cheng AF. Epidemiology of rifampin ADP-ribosyltransferase (arr-2) and metallo-beta-lactamase (blaIMP-4) gene cassettes in class 1 integrons in Acinetobacter strains isolated from blood cultures in 1997 to 2000. Antimicrob. Agents Chemother. 47(4), 1382-1390 (2003
-
(2003)
Antimicrob. Agents Chemother
, vol.47
, Issue.4
, pp. 1382-1390
-
-
Houang, E.T.1
Chu, Y.W.2
Lo, W.S.3
Chu, K.J.4
Cheng, A.F.5
-
35
-
-
82955162514
-
Molecular epidemiology and mechanisms of rifampicin resistance in Acinetobacter baumannii isolates from Italy
-
Giannouli M, Di Popolo A, Durante-Mangoni E et al. Molecular epidemiology and mechanisms of rifampicin resistance in Acinetobacter baumannii isolates from Italy. Int. J. Antimicrob. Agents 39(1), 58-63 (2012
-
(2012)
Int. J. Antimicrob. Agents
, vol.39
, Issue.1
, pp. 58-63
-
-
Giannouli, M.1
Di Popolo, A.2
Durante-Mangoni, E.3
-
36
-
-
84871664918
-
Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages
-
Zarrilli R, Pournaras S, Giannouli M, Tsakris A. Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages. Int. J. Antimicrob. Agents 41(1), 11-19 (2013
-
(2013)
Int. J. Antimicrob. Agents
, vol.41
, Issue.1
, pp. 11-19
-
-
Zarrilli, R.1
Pournaras, S.2
Giannouli, M.3
Tsakris, A.4
-
37
-
-
34147126025
-
Molecular epidemiology of a clonal outbreak of multidrug-resistant Acinetobacter baumannii in a university hospital in Italy
-
Zarrilli R, Casillo R, Di Popolo A et al. Molecular epidemiology of a clonal outbreak of multidrug-resistant Acinetobacter baumannii in a university hospital in Italy. Clin. Microbiol. Infect. 13(5), 481-489 (2007
-
(2007)
Clin. Microbiol. Infect
, vol.13
, Issue.5
, pp. 481-489
-
-
Zarrilli, R.1
Casillo, R.2
Di Popolo, A.3
-
38
-
-
77950471423
-
Molecular epidemiology of multi-drug resistant Acinetobacter baumannii in a tertiary care hospital in Naples, Italy, shows the emergence of a novel epidemic clone
-
Giannouli M, Cuccurullo S, Crivaro V et al. Molecular epidemiology of multi-drug resistant Acinetobacter baumannii in a tertiary care hospital in Naples, Italy, shows the emergence of a novel epidemic clone. J. Clin. Microbiol. 48(4), 1223-1230 (2010).
-
(2010)
J. Clin. Microbiol
, vol.48
, Issue.4
, pp. 1223-1230
-
-
Giannouli, M.1
Cuccurullo, S.2
Crivaro, V.3
-
39
-
-
84869211257
-
Clonal spread and patients' risk factors for acquisition of extensively drug-resistant Acinetobacter baumannii in a neonatal intensive care unit in Italy
-
Zarrilli R, Di Popolo A, Bagattini M et al. Clonal spread and patients' risk factors for acquisition of extensively drug-resistant Acinetobacter baumannii in a neonatal intensive care unit in Italy. J. Hosp. Infect. 82(4), 260-265 (2012
-
(2012)
J. Hosp. Infect
, vol.82
, Issue.4
, pp. 260-265
-
-
Zarrilli, R.1
Di Popolo, A.2
Bagattini, M.3
-
40
-
-
84885377048
-
Evaluation of the in vitro activity of fosfomycin tromethamine against Gram-negative bacterial strains recovered from community-And hospitalacquired urinary tract infections in Turkey
-
Demir T, Buyukguclu T. Evaluation of the in vitro activity of fosfomycin tromethamine against Gram-negative bacterial strains recovered from community-And hospitalacquired urinary tract infections in Turkey. Int. J. Infect. Dis. 17(11), e966-e970 (2013
-
(2013)
Int. J. Infect. Dis
, vol.17
, Issue.11
-
-
Demir, T.1
Buyukguclu, T.2
-
41
-
-
57349139420
-
Comparative genome sequence analysis of multidrug-resistant Acinetobacter baumannii
-
Adams MD, Goglin K, Molyneaux N et al. Comparative genome sequence analysis of multidrug-resistant Acinetobacter baumannii. J. Bacteriol. 190(24), 8053-8064 (2008
-
(2008)
J. Bacteriol
, vol.190
, Issue.24
, pp. 8053-8064
-
-
Adams, M.D.1
Goglin, K.2
Molyneaux, N.3
-
42
-
-
33748697027
-
Heteroresistance to colistin in multidrugresistant Acinetobacter baumannii
-
Li J, Rayner CR, Nation RL et al. Heteroresistance to colistin in multidrugresistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 50(9), 2946-2950 (2006
-
(2006)
Antimicrob. Agents Chemother
, vol.50
, Issue.9
, pp. 2946-2950
-
-
Li, J.1
Rayner, C.R.2
Nation, R.L.3
-
43
-
-
33747890430
-
Prevention of rifampicin resistance in Acinetobacter baumannii in an experimental pneumonia murine model, using rifampicin associated with imipenem or sulbactam
-
Pachon-Ibanez ME, Fernandez-Cuenca F, Docobo-Perez F, Pachon J, Pascual A. Prevention of rifampicin resistance in Acinetobacter baumannii in an experimental pneumonia murine model, using rifampicin associated with imipenem or sulbactam. J. Antimicrob. Chemother. 58(3), 689-692 (2006
-
(2006)
J. Antimicrob. Chemother
, vol.58
, Issue.3
, pp. 689-692
-
-
Pachon-Ibanez, M.E.1
Fernandez-Cuenca, F.2
Docobo-Perez, F.3
Pachon, J.4
Pascual, A.5
-
44
-
-
77149153364
-
Efficacy of rifampin and its combinations with imipenem, sulbactam, and colistin in experimental models of infection caused by imipenem-resistant Acinetobacter baumannii
-
Pachon-Ibanez ME, Docobo-Perez F, Lopez-Rojas L et al. Efficacy of rifampin and its combinations with imipenem, sulbactam, and colistin in experimental models of infection caused by imipenem-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 54(3), 1165-1172 (2010
-
(2010)
Antimicrob. Agents Chemother
, vol.54
, Issue.3
, pp. 1165-1172
-
-
Pachon-Ibanez, M.E.1
Docobo-Perez, F.2
Lopez-Rojas, L.3
-
45
-
-
12344303247
-
Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model
-
Montero A, Ariza J, Corbella X et al. Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model. J. Antimicrob. Chemother. 54(6), 1085-1091 (2004
-
(2004)
J. Antimicrob. Chemother
, vol.54
, Issue.6
, pp. 1085-1091
-
-
Montero, A.1
Ariza, J.2
Corbella, X.3
-
46
-
-
1442324767
-
In vitro double and triple synergistic activities of polymyxin B, imipenem, and rifampin against multidrug-resistant Acinetobacter baumannii
-
Yoon J, Urban C, Terzina C, Mariano N, Rahal JJ. In vitro double and triple synergistic activities of polymyxin B, imipenem, and rifampin against multidrug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 48(3), 753-757 (2004
-
(2004)
Antimicrob. Agents Chemother
, vol.48
, Issue.3
, pp. 753-757
-
-
Yoon, J.1
Urban, C.2
Terzina, C.3
Mariano, N.4
Rahal, J.J.5
-
47
-
-
35748930554
-
Comparative activities of colistin, rifampicin, imipenem, sulbactam/ ampicillin alone or in combination against epidemic multidrug-resistant Acinetobacter baumannii isolates producing OXA-58 carbapenemases
-
Tripodi M-F, Durante-Mangoni E, Fortunato R, Utili R, Zarrilli R. Comparative activities of colistin, rifampicin, imipenem, sulbactam/ ampicillin alone or in combination against epidemic multidrug-resistant. Acinetobacter baumannii isolates producing OXA-58 carbapenemases. Int. J. Antimicrob. Agents 30(6), 537-540 (2007
-
(2007)
Int. J. Antimicrob. Agents
, vol.30
, Issue.6
, pp. 537-540
-
-
Tripodi, M.-F.1
Durante-Mangoni, E.2
Fortunato, R.3
Utili, R.4
Zarrilli, R.5
-
48
-
-
84884233320
-
Systematic review and meta-Analysis of in vitro synergy of polymyxins and carbapenems
-
Zusman O, Avni T, Leibovici L et al. Systematic review and meta-Analysis of in vitro synergy of polymyxins and carbapenems. Antimicrob. Agents Chemother. 57(10), 5104-5111 (2013
-
(2013)
Antimicrob. Agents Chemother
, vol.57
, Issue.10
, pp. 5104-5111
-
-
Zusman, O.1
Avni, T.2
Leibovici, L.3
-
49
-
-
84876209645
-
Activities of vancomycin-containing regimens against colistin-resistant Acinetobacter baumannii clinical strains
-
O'Hara JA, Ambe LA, Casella LG et al. Activities of vancomycin-containing regimens against colistin-resistant Acinetobacter baumannii clinical strains. Antimicrob. Agents Chemother. 57(5), 2103-2108 (2013
-
(2013)
Antimicrob. Agents Chemother
, vol.57
, Issue.5
, pp. 2103-2108
-
-
O'hara, J.A.1
Ambe, L.A.2
Casella, L.G.3
-
50
-
-
84893488589
-
In vitro responses of Acinetobacter baumannii to two-And three-drug combinations following exposure to colistin and doripenem
-
Oleksiuk LM, Nguyen MH, Press EG et al. In vitro responses of Acinetobacter baumannii to two-And three-drug combinations following exposure to colistin and doripenem. Antimicrob. Agents Chemother. 58(2), 1195-1199 (2014
-
(2014)
Antimicrob. Agents Chemother
, vol.58
, Issue.2
, pp. 1195-1199
-
-
Oleksiuk, L.M.1
Nguyen, M.H.2
Press, E.G.3
-
52
-
-
84880260396
-
Synergistic activity of colistin and rifampin combination against multidrug-resistant Acinetobacter baumannii in an in vitro pharmacokinetic/ pharmacodynamic model
-
Lee HJ, Bergen PJ, Bulitta JB et al. Synergistic activity of colistin and rifampin combination against multidrug-resistant Acinetobacter baumannii in an in vitro pharmacokinetic/ pharmacodynamic model. Antimicrob. Agents Chemother. 57(8), 3738-3745 (2013
-
(2013)
Antimicrob. Agents Chemother
, vol.57
, Issue.8
, pp. 3738-3745
-
-
Lee, H.J.1
Bergen, P.J.2
Bulitta, J.B.3
-
53
-
-
33845654311
-
Colistin offers prolonged survival in experimental infection by multidrug-resistant Acinetobacter baumannii: The significance of co-Administration of rifampicin
-
Pantopoulou A, Giamarellos-Bourboulis EJ, Raftogannis M et al. Colistin offers prolonged survival in experimental infection by multidrug-resistant Acinetobacter baumannii: The significance of co-Administration of rifampicin. Int. J. Antimicrob. Agents 29(1), 51-55 (2007
-
(2007)
Int. J. Antimicrob. Agents
, vol.29
, Issue.1
, pp. 51-55
-
-
Pantopoulou, A.1
Giamarellos-Bourboulis, E.J.2
Raftogannis, M.3
-
54
-
-
79959214029
-
In vivo efficacy of glycopeptide-colistin combination therapies in a Galleria mellonella model of Acinetobacter baumannii infection
-
Hornsey M, Wareham DW. In vivo efficacy of glycopeptide-colistin combination therapies in a Galleria mellonella model of Acinetobacter baumannii infection. Antimicrob. Agents Chemother. 55(7), 3534-3537 (2011
-
(2011)
Antimicrob. Agents Chemother
, vol.55
, Issue.7
, pp. 3534-3537
-
-
Hornsey, M.1
Wareham, D.W.2
-
55
-
-
79954596970
-
In vitro activity of teicoplanin combined with colistin versus multidrug-resistant strains of Acinetobacter baumannii
-
Wareham DW, Gordon NC, Hornsey M. In vitro activity of teicoplanin combined with colistin versus multidrug-resistant strains of Acinetobacter baumannii. J. Antimicrob. Chemother. 66(5), 1047-1051 (2011
-
(2011)
J. Antimicrob. Chemother
, vol.66
, Issue.5
, pp. 1047-1051
-
-
Wareham, D.W.1
Gordon, N.C.2
Hornsey, M.3
-
56
-
-
84861173941
-
In vitro activity of telavancin in combination with colistin versus Gramnegative bacterial pathogens Antimicrob
-
Hornsey M, Longshaw C, Phee L, Wareham DW. In vitro activity of telavancin in combination with colistin versus Gramnegative bacterial pathogens Antimicrob. Agents Chemother. 56(6), 3080-3085 (2012
-
(2012)
Agents Chemother
, vol.56
, Issue.6
, pp. 3080-3085
-
-
Hornsey, M.1
Longshaw, C.2
Phee, L.3
Wareham, D.W.4
-
57
-
-
84872903587
-
In vivo efficacy of telavancin/colistin combination therapy in a Galleria mellonella model of Acinetobacter baumannii infection
-
Hornsey M, Phee L, Longshaw C, Wareham DW. In vivo efficacy of telavancin/colistin combination therapy in a Galleria mellonella model of Acinetobacter baumannii infection. Int. J. Antimicrob. Agents. 41(3), 285-287 (2013
-
(2013)
Int. J. Antimicrob. Agents
, vol.41
, Issue.3
, pp. 285-287
-
-
Hornsey, M.1
Phee, L.2
Longshaw, C.3
Wareham, D.W.4
-
58
-
-
84890569234
-
In vitro activity of daptomycin in combination with low-dose colistin against a diverse collection of Gram-negative bacterial pathogens
-
Phee L, Hornsey M, Wareham DW. In vitro activity of daptomycin in combination with low-dose colistin against a diverse collection of Gram-negative bacterial pathogens. Eur. J. Clin. Microbiol. Infect. Dis. 32(10), 1291-1294 (2013
-
(2013)
Eur. J. Clin. Microbiol. Infect. Dis
, vol.32
, Issue.10
, pp. 1291-1294
-
-
Phee, L.1
Hornsey, M.2
Wareham, D.W.3
-
59
-
-
84866039806
-
Efficacy of tigecycline/colistin combination in a pneumonia model caused by extensively drug-resistant Acinetobacter baumannii
-
Mutlu Yilmaz E, Sunbul M, Aksoy A, Yilmaz H, Guney AK, Guvenc T. Efficacy of tigecycline/colistin combination in a pneumonia model caused by extensively drug-resistant Acinetobacter baumannii. Int. J. Antimicrob. Agents. 40(4), 332-336 (2012
-
(2012)
Int. J. Antimicrob. Agents
, vol.40
, Issue.4
, pp. 332-336
-
-
Mutlu Yilmaz, E.1
Sunbul, M.2
Aksoy, A.3
Yilmaz, H.4
Guney, A.K.5
Guvenc, T.6
-
60
-
-
84893505135
-
In vitro pharmacodynamics of polymyxin B and tigecycline alone and in combination against carbapenem resistant Acinetobacter baumannii
-
Hagihara M, Housman ST, Nicolau DP, Kuti JL. In vitro pharmacodynamics of polymyxin B and tigecycline alone and in combination against carbapenem resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 58(2), 874-879 (2014
-
(2014)
Antimicrob. Agents Chemother
, vol.58
, Issue.2
, pp. 874-879
-
-
Hagihara, M.1
Housman, S.T.2
Nicolau, D.P.3
Kuti, J.L.4
-
61
-
-
84868012115
-
In vitro and in vivo antimicrobial activities of gallium nitrate against multidrug-resistant Acinetobacter baumannii
-
Antunes LC, Imperi F, Minandri F, Visca P. In vitro and in vivo antimicrobial activities of gallium nitrate against multidrug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 56(11), 5961-5970 (2012
-
(2012)
Antimicrob. Agents Chemother
, vol.56
, Issue.11
, pp. 5961-5970
-
-
Antunes, L.C.1
Imperi, F.2
Minandri, F.3
Visca, P.4
-
62
-
-
80054933214
-
In vitro activity of colistin or sulbactam in combination with fosfomycin or imipenem against clinical isolates of carbapenem-resistant Acinetobacter baumannii producing OXA-23 carbapenemases
-
Santimaleeworagun W, Wongpoowarak P, Chayakul P, Pattharachayakul S, Tansakul P, Garey KW. In vitro activity of colistin or sulbactam in combination with fosfomycin or imipenem against clinical isolates of carbapenem-resistant Acinetobacter baumannii producing OXA-23 carbapenemases. Southeast Asian J. Trop. Med. Public Health 42(4), 890-900 (2011
-
(2011)
Southeast Asian J. Trop. Med. Public Health
, vol.42
, Issue.4
, pp. 890-900
-
-
Santimaleeworagun, W.1
Wongpoowarak, P.2
Chayakul, P.3
Pattharachayakul, S.4
Tansakul, P.5
Garey, K.W.6
-
63
-
-
33749246411
-
The significance of Acinetobacter baumannii bacteraemia compared with Klebsiella pneumoniae bacteraemia: Risk factors and outcomes
-
Robenshtok E, Paul M, Leibovici L et al. The significance of Acinetobacter baumannii bacteraemia compared with Klebsiella pneumoniae bacteraemia: Risk factors and outcomes. J. Hosp. Infect. 64(3), 282-287 (2006
-
(2006)
J. Hosp. Infect
, vol.64
, Issue.3
, pp. 282-287
-
-
Robenshtok, E.1
Paul, M.2
Leibovici, L.3
-
64
-
-
33846116186
-
Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization
-
Sunenshine RH, Wright M-O, Maragakis LL et al. Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization. Emerg. Infect. Dis. 13(1), 97-103 (2007
-
(2007)
Emerg. Infect. Dis
, vol.13
, Issue.1
, pp. 97-103
-
-
Sunenshine, R.H.1
Wright, M.-O.2
Maragakis, L.L.3
-
65
-
-
33947605898
-
Attributable mortality of nosocomial Acinetobacter bacteremia
-
Grupper M, Sprecher H, Mashiach T, Finkelstein R. Attributable mortality of nosocomial Acinetobacter bacteremia. Infect. Control Hosp. Epidemiol. 28(3), 293-298 (2007
-
(2007)
Infect. Control Hosp. Epidemiol
, vol.28
, Issue.3
, pp. 293-298
-
-
Grupper, M.1
Sprecher, H.2
Mashiach, T.3
Finkelstein, R.4
-
66
-
-
33746093374
-
Attributable mortality of Acinetobacter baumannii infections in critically ill patients: A systematic review of matched cohort and case-control studies
-
Falagas ME, Bliziotis IA, Siempos II. Attributable mortality of Acinetobacter baumannii infections in critically ill patients: A systematic review of matched cohort and case-control studies. Crit. Care 10(2), R48 (2006
-
(2006)
Crit. Care
, vol.10
, Issue.2
-
-
Falagas, M.E.1
Bliziotis, I.A.2
Siempos, I.I.3
-
67
-
-
36448983944
-
Polimixin B for the treatment of multidrugresistant pathogens: A critical review
-
Zavascki AP, Goldani LZ, Li J, Nation RL. Polimixin B for the treatment of multidrugresistant pathogens: A critical review. J. Antimicrob. Chemother. 60(6), 1206-1215 (2007
-
(2007)
J. Antimicrob. Chemother
, vol.60
, Issue.6
, pp. 1206-1215
-
-
Zavascki, A.P.1
Goldani, L.Z.2
Li, J.3
Nation, R.L.4
-
68
-
-
11144285626
-
Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria
-
Li J, Nation RL, Milne RW, Turnidge JD, Coulthard K. Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria. Int. J. Antimicrob. Agents 25(1), 11-25 (2005
-
(2005)
Int. J. Antimicrob. Agents
, vol.25
, Issue.1
, pp. 11-25
-
-
Li, J.1
Nation, R.L.2
Milne, R.W.3
Turnidge, J.D.4
Coulthard, K.5
-
69
-
-
33747362870
-
Colistin: The re-emerging antibiotic for multidrugresistant Gram-negative bacterial infections
-
Li J, Nation RL, Turnidge JD et al. Colistin: The re-emerging antibiotic for multidrugresistant Gram-negative bacterial infections. Lancet Infect. Dis. 6(9), 589-601 (2006
-
(2006)
Lancet Infect. Dis
, vol.6
, Issue.9
, pp. 589-601
-
-
Li, J.1
Nation, R.L.2
Turnidge, J.D.3
-
70
-
-
83655167235
-
Colistin pharmacokinetics: The fog is lifting
-
Couet W, Grégoire N, Marchand S, Mimoz O. Colistin pharmacokinetics: The fog is lifting. Clin. Microbiol. Infect. 18(1), 30-39 (2012
-
(2012)
Clin. Microbiol. Infect
, vol.18
, Issue.1
, pp. 30-39
-
-
Couet, W.1
Grégoire, N.2
Marchand, S.3
Mimoz, O.4
-
71
-
-
77957569216
-
Steady-state pharmacokinetics and BAL concentration of colistin in critically ill patients after IV colistin methanesulfonate administration
-
Imberti R, Cusato M, Villani P et al. Steady-state pharmacokinetics and BAL concentration of colistin in critically ill patients after IV colistin methanesulfonate administration. Chest 138(6), 1333-1339 (2010
-
(2010)
Chest
, vol.138
, Issue.6
, pp. 1333-1339
-
-
Imberti, R.1
Cusato, M.2
Villani, P.3
-
72
-
-
78649823833
-
Aerosolized plus intravenous colistin versus intravenous colistin alone for the treatment of ventilator-Associated pneumonia: A matched case-control study
-
Kofteridis DP, Alexopoulou C, Valachis A et al. Aerosolized plus intravenous colistin versus intravenous colistin alone for the treatment of ventilator-Associated pneumonia: A matched case-control study. Clin. Infect. Dis. 51(11), 1238-1244 (2010
-
(2010)
Clin. Infect. Dis
, vol.51
, Issue.11
, pp. 1238-1244
-
-
Kofteridis, D.P.1
Alexopoulou, C.2
Valachis, A.3
-
73
-
-
78149480085
-
Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-Associated pneumonia caused by Gram-negative bacteria
-
Rattanaumpawan P, Lorsutthitham J, Ungprasert P, Angkasekwinai N, Thamlikitkul V. Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-Associated pneumonia caused by Gram-negative bacteria. J. Antimicrob. Chemother. 65(12), 2645-2649 (2010
-
(2010)
J. Antimicrob. Chemother
, vol.65
, Issue.12
, pp. 2645-2649
-
-
Rattanaumpawan, P.1
Lorsutthitham, J.2
Ungprasert, P.3
Angkasekwinai, N.4
Thamlikitkul, V.5
-
74
-
-
80054088449
-
Incidence of and risk factors for colistin-Associated nephrotoxicity in a large academic health system
-
Pogue JM, Lee J, Marchaim D et al. Incidence of and risk factors for colistin-Associated nephrotoxicity in a large academic health system. Clin. Infect. Dis. 53(9), 879-884 (2011
-
(2011)
Clin. Infect. Dis
, vol.53
, Issue.9
, pp. 879-884
-
-
Pogue, J.M.1
Lee, J.2
Marchaim, D.3
-
75
-
-
84880379313
-
Colistin and rifampicin compared with colistin alone for the treatment of serious infections due to extensively drug-resistant Acinetobacter baumannii A multicentre, randomised, clinical trial
-
Durante-Mangoni E, Signoriello G, Andini R et al. Colistin and rifampicin compared with colistin alone for the treatment of serious infections due to extensively drug-resistant Acinetobacter baumannii. A multicentre, randomised, clinical trial. Clin. Infect. Dis. 57(3), 349-358 (2013
-
(2013)
Clin. Infect. Dis
, vol.57
, Issue.3
, pp. 349-358
-
-
Durante-Mangoni, E.1
Signoriello, G.2
Andini, R.3
-
76
-
-
0038369924
-
Treatment of multidrug-resistant Acinetobacter baumannii ventilator-Associated pneumonia (VAP) with intravenous colistin: A comparison with imipenem-susceptible VAP
-
Garnacho-Montero J, Ortiz-Leyba C, Jiménez-Jiménez FJ et al. Treatment of multidrug-resistant Acinetobacter baumannii ventilator-Associated pneumonia (VAP) with intravenous colistin: A comparison with imipenem-susceptible VAP. Clin. Infect. Dis. 36(9), 1111-1118 (2003
-
(2003)
Clin. Infect. Dis
, vol.36
, Issue.9
, pp. 1111-1118
-
-
Garnacho-Montero, J.1
Ortiz-Leyba, C.2
Jiménez-Jiménez, F.J.3
-
77
-
-
23744504983
-
Safety and efficacy of colistin in Acinetobacter and Pseudomonas infections: A prospective cohort study
-
Reina R, Estenssoro E, Sáenz G et al. Safety and efficacy of colistin in Acinetobacter and Pseudomonas infections: A prospective cohort study. Intensive Care Med. 31(8), 1058-1065 (2005
-
(2005)
Intensive Care Med
, vol.31
, Issue.8
, pp. 1058-1065
-
-
Reina, R.1
Estenssoro, E.2
Sáenz, G.3
-
78
-
-
0032939527
-
Intravenous colistin as therapy for nosocomial infections caused by multi-drug resistant Pseudomonas aeruginosa and Acinetobacter baumannii
-
Levin AS, Barone AA, Penço J et al. Intravenous colistin as therapy for nosocomial infections caused by multi-drug resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Clin. Infect. Dis. 28(5), 1008-1011 (1999
-
(1999)
Clin. Infect. Dis
, vol.28
, Issue.5
, pp. 1008-1011
-
-
Levin, A.S.1
Barone, A.A.2
Penço, J.3
-
79
-
-
23044515861
-
Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis
-
Kasiakou SK, Michalopoulos A, Soteriades ES, Samonis G, Sermaides GJ, Falagas ME. Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis. Antimicrob. Agents Chemother. 49(8), 3136-3146 (2005
-
(2005)
Antimicrob. Agents Chemother
, vol.49
, Issue.8
, pp. 3136-3146
-
-
Kasiakou, S.K.1
Michalopoulos, A.2
Soteriades, E.S.3
Samonis, G.4
Sermaides, G.J.5
Falagas, M.E.6
-
80
-
-
50149096410
-
Colistin monotherapy vs. Combination therapy: Evidence from microbiological, animal and clinical studies
-
Petrosillo N, Ioannidou E, Falagas ME. colistin monotherapy vs. combination therapy: Evidence from microbiological, animal and clinical studies. Clin. Microbiol. Infect. 14(9), 816-827 (2008
-
(2008)
Clin. Microbiol. Infect
, vol.14
, Issue.9
, pp. 816-827
-
-
Petrosillo, N.1
Ioannidou, E.2
Falagas, M.E.3
-
81
-
-
74249103796
-
Rifampin combination therapy for nonmycobacterial infections
-
Forrest GN, Tamura K. Rifampin combination therapy for nonmycobacterial infections. Clin. Microbiol. Rev. 23(1), 14-34 (2010
-
(2010)
Clin. Microbiol. Rev
, vol.23
, Issue.1
, pp. 14-34
-
-
Forrest, G.N.1
Tamura, K.2
-
82
-
-
33747874139
-
Rifampicin/imipenem combination in the treatment of carbapenem-resistant Acinetobacter baumannii infections
-
Saballs M, Pujol M, Tubau F et al. Rifampicin/imipenem combination in the treatment of carbapenem-resistant Acinetobacter baumannii infections. J. Antimicrob. Chemother. 58(3), 697-700 (2006
-
(2006)
J. Antimicrob. Chemother
, vol.58
, Issue.3
, pp. 697-700
-
-
Saballs, M.1
Pujol, M.2
Tubau, F.3
-
83
-
-
22944482529
-
Combined colistin and rifampicin therapy for carbapenem-resistant Acinetobacter baumannii infections: Clinical outcome and adverse events
-
Petrosillo N, Chinello P, Proietti MF et al. Combined colistin and rifampicin therapy for carbapenem-resistant Acinetobacter baumannii infections: Clinical outcome and adverse events. Clin. Microbiol. Infect. 11(8), 682-683 (2005
-
(2005)
Clin. Microbiol. Infect
, vol.11
, Issue.8
, pp. 682-683
-
-
Petrosillo, N.1
Chinello, P.2
Proietti, M.F.3
-
84
-
-
33745586136
-
Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii
-
Motaouakkil S, Charra B, Hachimi A et al. Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii. J. Infect. 53(4), 274-278 (2006
-
(2006)
J. Infect
, vol.53
, Issue.4
, pp. 274-278
-
-
Motaouakkil, S.1
Charra, B.2
Hachimi, A.3
-
85
-
-
38349181470
-
Colistin and rifampicin in the treatment of multidrugresistant Acinetobacter baumannii infections
-
Bassetti M, Repetto E, Righi E et al. Colistin and rifampicin in the treatment of multidrugresistant Acinetobacter baumannii infections. J. Antimicrob. Chemother. 61(2), 417-420 (2008
-
(2008)
J. Antimicrob. Chemother
, vol.61
, Issue.2
, pp. 417-420
-
-
Bassetti, M.1
Repetto, E.2
Righi, E.3
-
86
-
-
49749141456
-
Colistin and rifampicin combination in the treatment of ventilator-Associated pneumonia caused by carbapenem resistant Acinetobacter baumannii
-
Song JY, Lee J, Heo JY et al. Colistin and rifampicin combination in the treatment of ventilator-Associated pneumonia caused by carbapenem resistant Acinetobacter baumannii. Int. J. Antimicrob. Agents 32(3), 281-284 (2008
-
(2008)
Int. J. Antimicrob. Agents
, vol.32
, Issue.3
, pp. 281-284
-
-
Song, J.Y.1
Lee, J.2
Heo, J.Y.3
-
87
-
-
33751091224
-
Effectiveness and nephrotoxicity of colistin monotherapy vs colistin-meropenem combination therapy for multidrug-resistant Gram-negative bacterial infections
-
Falagas ME, Rafailidis PI, Kasiakou SK, Hatzopoulou P, Michalopoulos A. Effectiveness and nephrotoxicity of colistin monotherapy vs. colistin-meropenem combination therapy for multidrug-resistant Gram-negative bacterial infections. Clin. Microbiol. Infect. 12(12), 1227-1230 (2006
-
(2006)
Clin. Microbiol. Infect
, vol.12
, Issue.12
, pp. 1227-1230
-
-
Falagas, M.E.1
Rafailidis, P.I.2
Kasiakou, S.K.3
Hatzopoulou, P.4
Michalopoulos, A.5
-
88
-
-
79955484275
-
Clinical implications of beta-lactam aminoglycoside synergism: Systematic review of randomised trials
-
Marcus R, Paul M, Elphick H, Leibovici L. Clinical implications of beta-lactam aminoglycoside synergism: Systematic review of randomised trials. Int. J. Antimicrob. Agents 37(6), 491-503 (2011
-
(2011)
Int. J. Antimicrob. Agents
, vol.37
, Issue.6
, pp. 491-503
-
-
Marcus, R.1
Paul, M.2
Elphick, H.3
Leibovici, L.4
-
89
-
-
60349103085
-
Do we still need the aminoglycosides?
-
Durante Mangoni E, Grammatikos A, Utili R, Falagas ME. Do we still need the aminoglycosides?. Int. J. Antimicrob. Agents 33(3), 201-205 (2009
-
(2009)
Int. J. Antimicrob. Agents
, vol.33
, Issue.3
, pp. 201-205
-
-
Durante Mangoni, E.1
Grammatikos, A.2
Utili, R.3
Falagas, M.E.4
-
90
-
-
0019921978
-
Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: A prospective study
-
Korzeniowski O, Sande MA. Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: A prospective study. Ann. Intern. Med. 97(4), 496-503 (1982
-
(1982)
Ann. Intern. Med
, vol.97
, Issue.4
, pp. 496-503
-
-
Korzeniowski, O.1
Sande, M.A.2
-
91
-
-
77954888053
-
Multiresistant Acinetobacter baumannii infections: Epidemiology and management
-
Garnacho-Montero J, Amaya-Villar R. Multiresistant Acinetobacter baumannii infections: Epidemiology and management. Curr. Opin. Infect. Dis. 23(4), 332-339 (2010
-
(2010)
Curr. Opin. Infect. Dis
, vol.23
, Issue.4
, pp. 332-339
-
-
Garnacho-Montero, J.1
Amaya-Villar, R.2
-
92
-
-
70849121220
-
Rifampicin combined regimens for Gram-negative infections: Data from the literature
-
Drapeau, CM, Grilli E, Petrosillo N. Rifampicin combined regimens for Gram-negative infections: Data from the literature. Int. J. Antimicrob. Agents 35(1), 39-44 (2010
-
(2010)
Int. J. Antimicrob. Agents 35
, vol.1
, pp. 39-44
-
-
Drapeau, C.M.1
Grilli, E.2
Petrosillo, N.3
-
93
-
-
78649879211
-
How soon is now? the urgent need for randomized, controlled trials evaluating treatment of multidrugresistant bacterial infection
-
Paterson DL, Rogers BA. How soon is now?. The urgent need for randomized, controlled trials evaluating treatment of multidrugresistant bacterial infection. Clin. Infect. Dis. 51(11), 1245-1247 (2010
-
(2010)
Clin. Infect. Dis
, vol.51
, Issue.11
, pp. 1245-1247
-
-
Paterson, D.L.1
Rogers, B.A.2
-
94
-
-
84876933127
-
Colistin vs the combination of colistin and rifampicin for the treatment of carbapenemresistant Acinetobacter baumannii ventilatorassociated pneumonia
-
Aydemir H, Akduman D, Piskin N et al. Colistin vs. the combination of colistin and rifampicin for the treatment of carbapenemresistant Acinetobacter baumannii ventilatorassociated pneumonia. Epidemiol. Infect. 141(6), 1214-1222 (2013
-
(2013)
Epidemiol. Infect
, vol.141
, Issue.6
, pp. 1214-1222
-
-
Aydemir, H.1
Akduman, D.2
Piskin, N.3
-
95
-
-
84904601392
-
-
Presented at: Interscience Conference on Antimicrobial Agents and Chemotherapy 2012, San Francisco, CA, USA 9-12 September 2012 (K-1602
-
Sirijatuphat R, Koomanachai P, Thamlikitkul V. Randomized controlled trial of colistin (COL) vs. colistin plus fosfomycin (COL + FOS) for infections caused by carbapenemresistant (CR) Acinetobacter baumannii. Presented at: Interscience Conference on Antimicrobial Agents and Chemotherapy 2012, San Francisco, CA, USA, 9-12 September 2012 (K-1602
-
Randomized Controlled Trial of Colistin (COL) Vs. Colistin Plus Fosfomycin (COL + FOS) for Infections Caused by Carbapenemresistant (CR) Acinetobacter Baumannii
-
-
Sirijatuphat, R.1
Koomanachai, P.2
Thamlikitkul, V.3
-
97
-
-
84883465753
-
In vitro activity of sitafloxacin against carbapenem-resistant Acinetobacter baumannii
-
Thamlikitkul V, Tiengrim S. In vitro activity of sitafloxacin against carbapenem-resistant Acinetobacter baumannii. Int. J. Antimicrob. Agents. 42(3), 284-285 (2013
-
(2013)
Int. J. Antimicrob. Agents
, vol.42
, Issue.3
, pp. 284-285
-
-
Thamlikitkul, V.1
Tiengrim, S.2
-
98
-
-
84893471192
-
Colistin-glycopeptide combination in critically ill patients with Gram negative infection: The clinical experience
-
Petrosillo N, Giannella M, Antonelli M et al. Colistin-glycopeptide combination in critically ill patients with Gram negative infection: The clinical experience. Antimicrob. Agents Chemother. 58(2), 851-858 (2014
-
(2014)
Antimicrob. Agents Chemother
, vol.58
, Issue.2
, pp. 851-858
-
-
Petrosillo, N.1
Giannella, M.2
Antonelli, M.3
|